Baldwin Wealth Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$715K Sell
3,668
-113
-3% -$23.4K 0.05% 127
2026
Q1
$849K Sell
3,781
-176
-4% -$43.9K 0.06% 112
2025
Q4
$953K Sell
3,957
-100
-2% -$25.6K 0.06% 116
2025
Q3
$1.11M Sell
4,057
-365
-8% -$99.7K 0.07% 105
2025
Q2
$1.14M Sell
4,422
-815
-16% -$194K 0.08% 97
2025
Q1
$1.17M Sell
5,237
-60
-1% -$14K 0.08% 95
2024
Q4
$1.21M Sell
5,297
-790
-13% -$190K 0.08% 99
2024
Q3
$1.49M Buy
6,087
+42
+0.7% +$9.38K 0.1% 102
2024
Q2
$1.16M Sell
6,045
-2,300
-28% -$467K 0.09% 95
2024
Q1
$1.65M Sell
8,345
-540
-6% -$98.9K 0.12% 88
2023
Q4
$1.53M Sell
8,885
-2,795
-24% -$429K 0.12% 89
2023
Q3
$1.73M Sell
11,680
-214
-2% -$38.7K 0.15% 86
2023
Q2
$2.6M Sell
11,894
-1,010
-8% -$225K 0.21% 84
2023
Q1
$2.83M Sell
12,904
-126
-1% -$27.3K 0.25% 82
2022
Q4
$2.71M Buy
13,030
+12,959
+18,252% +$2.85M 0.25% 84
2022
Q3
$16K Sell
71
-26
-27% -$5.92K ﹤0.01% 465
2022
Q2
$20K Hold
97
﹤0.01% 474
2022
Q1
$24K Hold
97
﹤0.01% 460
2021
Q4
$25K Buy
97
+12
+14% +$3.11K ﹤0.01% 427
2021
Q3
$22K Hold
85
﹤0.01% 448
2021
Q2
$21K Hold
85
﹤0.01% 468
2021
Q1
$16K Sell
85
-7
-8% -$1.4K ﹤0.01% 480
2020
Q4
$20K Hold
92
﹤0.01% 405
2020
Q3
$16K Buy
92
+9
+11% +$1.66K ﹤0.01% 405
2020
Q2
$16K Hold
83
﹤0.01% 406
2020
Q1
$12K Buy
+83
New +$13.2K ﹤0.01% 416

Other funds holding RMD

Baldwin Wealth Partners's RMD Position: Q2 2026 in Review

Baldwin Wealth Partners reduced its ResMed (RMD) stake by 3% in Q2 2026, selling an estimated $23.4K and leaving 3,668 shares worth $715K. The position accounts for 0.05% of the portfolio, ranked #127.

Baldwin Wealth Partners first reported a position in RMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.83M in Q1 2023. 309 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Baldwin Wealth Partners held 3,668 shares of ResMed worth $715K as of Q2 2026.
  • Baldwin Wealth Partners sold 113 ResMed shares in Q2 2026, an estimated $23.4K.
  • ResMed made up 0.05% of Baldwin Wealth Partners's portfolio in Q2 2026, its #127 holding.
  • Baldwin Wealth Partners first reported a position in ResMed in Q1 2020 and has held it in 26 quarters since.
  • Baldwin Wealth Partners's ResMed position peaked at $2.83M in Q1 2023.
  • 309 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.